Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Drive Innovation

How patient-centered pioneers are blurring industry lines

The global pandemic has impacted people’s well-being over the past two years.

Partner, Mercer
Research Manager

NorthShore – Edward-Elmhurst Health has an ambitious program to integrate genomics into primary care. The results so far are positive, with 95% of NorthShore primary care doctors utilizing genomics in their practice.

Chief Innovation and Transformation Officer, NorthShore – Edward-Elmhurst Health

Consumers want what they’re used to: a digitally-enabled world. Can pharmacy keep up?

Partner, Health and Life Sciences, Oliver Wyman
Engagement Manager, Health and Life Sciences, Oliver Wyman

Walmart's value proposition on healthcare innovation

Walmart touches healthcare in a number of ways — as a large employer and an entity hoping to disrupt how care is delivered.

Global Leader, Health and Life Sciences, Oliver Wyman
Executive Chairman and CEO, Transcarent
Executive Vice President, Health and Wellness, Walmart

Time is running out for companies to meet their ambitious carbon neutrality targets. Leaders must build a corporate culture around sustainability.

Partner, Health and Life Sciences, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

What healthcare can learn from digital and mobile banking, instant loans and lines of credit, and micro payments.

President, CareJourney
President, Fifth Third Bancorp

Cell and gene therapies hold tremendous promise for patients and the industry, but new business models are needed to get innovations to patients.

Principal, Health and Life Sciences, Oliver Wyman

Using health IT to tackle health equity and opening multiple front doors for patients were a couple of themes that emerged at three big health conferences.

Senior Editor, Health and Life Sciences, Oliver Wyman

In today's hyperconnected world, organizations have to work together to defend against cyber attacks. And they need to embed secure technology and procedures more widely.

Partner, Digital and Financial Services, Cyber Platform Lead, Oliver Wyman
Senior Advisor, Oliver Wyman

As the Biden administration leans into the Cancer Moonshot 2.0, the life sciences industry has the opportunity to launch a new era of precision oncology. How can we accelerate progress toward truly personalized medicine and revolutionize cancer care?

Chief Strategy Officer, COTA, Inc.

Insights in your inbox

Subscribe